Surgical Site Infections
2
Pipeline Programs
1
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Ondine BiomedicalBC - Vancouver
3 programs1
1
nasal antimicrobial photodisinfection therapyPhase 31 trial
methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activationPhase 21 trial
Nasal antimicrobial photodisinfection therapyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Ondine Biomedicalnasal antimicrobial photodisinfection therapy
Ondine Biomedicalmethylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation
Ondine BiomedicalNasal antimicrobial photodisinfection therapy
Clinical Trials (3)
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
Start: Dec 2024Est. completion: Apr 2026
Phase 3Recruiting
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
Start: Feb 2022Est. completion: Aug 2022
Phase 2Completed
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
Start: Jan 2026Est. completion: Apr 2026
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials
1 companies competing in this space